ATE546543T1 - Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase - Google Patents

Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase

Info

Publication number
ATE546543T1
ATE546543T1 AT08765357T AT08765357T ATE546543T1 AT E546543 T1 ATE546543 T1 AT E546543T1 AT 08765357 T AT08765357 T AT 08765357T AT 08765357 T AT08765357 T AT 08765357T AT E546543 T1 ATE546543 T1 AT E546543T1
Authority
AT
Austria
Prior art keywords
epha4
secretase
screening method
new substrate
gamma secretase
Prior art date
Application number
AT08765357T
Other languages
English (en)
Inventor
Eiji Inoue
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE546543T1 publication Critical patent/ATE546543T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08765357T 2007-06-08 2008-06-09 Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase ATE546543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94268707P 2007-06-08 2007-06-08
PCT/JP2008/060567 WO2008150010A1 (ja) 2007-06-08 2008-06-09 γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法

Publications (1)

Publication Number Publication Date
ATE546543T1 true ATE546543T1 (de) 2012-03-15

Family

ID=40093812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08765357T ATE546543T1 (de) 2007-06-08 2008-06-09 Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase

Country Status (5)

Country Link
US (2) US7910324B2 (de)
EP (1) EP2166110B1 (de)
JP (1) JP5511377B2 (de)
AT (1) ATE546543T1 (de)
WO (1) WO2008150010A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910324B2 (en) 2007-06-08 2011-03-22 Eisai R&D Management Co., Ltd. Method of screening for compounds which affect the processing of EphA4 by γ-secretase
US20090191580A1 (en) * 2007-07-19 2009-07-30 Eisai R & D Management Co., Ltd. METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
JPWO2009017234A1 (ja) * 2007-08-01 2010-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質c−Retを利用したスクリーニング方法
JP5580598B2 (ja) 2007-11-15 2014-08-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法
US7892769B2 (en) 2007-11-30 2011-02-22 Eisai R&D Management Co., Ltd. Processing of EphA4 polypeptide by γ-secretase activity
WO2010141974A1 (en) * 2009-06-10 2010-12-16 The University Of Melbourne Therapeutic applications
JP6059017B2 (ja) * 2010-12-17 2017-01-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼラチナーゼによるEphA4の切断反応を指標としたスクリーニング方法
JP5961608B2 (ja) 2011-04-25 2016-08-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 EphA4細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
WO2017043466A1 (ja) 2015-09-08 2017-03-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗EphA4抗体
JP6877419B2 (ja) * 2015-10-27 2021-05-26 ザ ユニバーシティー オブ クイーンズランド 治療の方法およびそのために有用な剤
AR119303A1 (es) 2019-07-01 2021-12-09 Eisai R&D Man Co Ltd Anticuerpo anti-epha4 humano
CA3195085A1 (en) * 2020-12-24 2022-06-30 Eisai R&D Management Co., Ltd. Therapeutic pharmaceutical composition for amyotrophic lateral sclerosis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6887698A (en) 1997-04-08 1998-10-30 Sugen, Inc. Study and treatment of diseases related to specific cellular functions of receptor protein tyrosine kinases
US20020068361A1 (en) * 1997-04-08 2002-06-06 Douglas Clary Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner
US20060241074A1 (en) * 2001-08-14 2006-10-26 The General Hospital Corporation Methods for treatment of pain
US20070026409A1 (en) * 2001-08-14 2007-02-01 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
AU2002324700A1 (en) 2001-08-14 2003-03-03 Bayer Ag Nucleic acid and amino acid sequences involved in pain
JP2003169699A (ja) 2001-12-10 2003-06-17 Japan Science & Technology Corp 特異的γプロテアーゼ阻害剤のスクリーニング方法
JP2004000060A (ja) 2002-05-31 2004-01-08 Otsuka Pharmaceut Co Ltd アミロイドβ産生に影響を与える化合物のスクリーニング方法
HRP20050461A2 (en) 2002-11-26 2005-08-31 Pharmacia & Upjohn Company Llc Soluble notch-based substrates for gamma secretase and methods and compositions for using same
WO2005045028A1 (ja) 2003-11-10 2005-05-19 Osaka Industrial Promotion Organization セル・フリー・Notch切断分析方法及び薬剤スクリーニング方法
TW200538739A (en) 2004-02-27 2005-12-01 Oncotherapy Science Inc EphA4 as therapeutic target of PRC and PDACa
EP1662259A1 (de) * 2004-11-25 2006-05-31 Cellzome Ag Verwendung von Eph Rezeptor-Inhibitoren zur Behandlung von neurodegenerativen Erkrankungen
GB0427023D0 (en) 2004-12-09 2005-01-12 Merck Sharp & Dohme Assay method
US20070051145A1 (en) * 2005-09-02 2007-03-08 Ez Trend Technology Co.,Ltd Electric lock
EP1947193A1 (de) * 2007-01-17 2008-07-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Screening-Verfahren für antidiabetische Zusammensetzungen
US7910324B2 (en) * 2007-06-08 2011-03-22 Eisai R&D Management Co., Ltd. Method of screening for compounds which affect the processing of EphA4 by γ-secretase
CA2692604A1 (en) * 2007-07-13 2009-01-22 Elan Pharmaceuticals, Inc. Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase
US20090191580A1 (en) * 2007-07-19 2009-07-30 Eisai R & D Management Co., Ltd. METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
US7892769B2 (en) * 2007-11-30 2011-02-22 Eisai R&D Management Co., Ltd. Processing of EphA4 polypeptide by γ-secretase activity
US20100113415A1 (en) * 2008-05-29 2010-05-06 Rajapakse Hemaka A Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer

Also Published As

Publication number Publication date
EP2166110B1 (de) 2012-02-22
WO2008150010A1 (ja) 2008-12-11
JPWO2008150010A1 (ja) 2010-08-26
US8137926B2 (en) 2012-03-20
US7910324B2 (en) 2011-03-22
EP2166110A1 (de) 2010-03-24
EP2166110A4 (de) 2010-07-28
US20110111444A1 (en) 2011-05-12
JP5511377B2 (ja) 2014-06-04
US20090142788A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
ATE546543T1 (de) Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
EP1679508A4 (de) Biosensor und verfahren zu dessen herstellung
ATE526333T1 (de) Reagentien zum nachweis von hypochloriger säure
ATE525482T1 (de) Nanoreporter und verfahren zu deren herstellung und verwendung
EP1996718A4 (de) Toxizitätsscreeningverfahren
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
NO20080371L (no) Fremgangsmate for a forutsi responsen overfor en behandling
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2007045865A3 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders such as schizophrenia
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2009011426A1 (ja) γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
WO2009064006A1 (ja) γ-セクレターゼの新規基質EphA7を利用したスクリーニング方法
WO2009017234A1 (ja) γ-セクレターゼの新規基質c-Retを利用したスクリーニング方法
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
DK1613772T3 (da) Fremgangsmåde til bestemmelse af tilstanden af jord
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
DK1612275T3 (da) Fremgangsmåder og sammensætninger til karakterisering af et redoxreagenssystemenzym
TN2009000348A1 (en) A method of identification of cells that show sensitivity to modulation of signaling mediated by a fibroblast growth factor receptor or a variant thereof
ES2566506T3 (es) Método de test de control de calidad de una muestra que contiene factor XIII
DE602006004851D1 (de) Nachweisverfahren für ljungan-virus